Hubei Guangji Pharmaceutical Co Ltd (000952) - Total Assets
Based on the latest financial reports, Hubei Guangji Pharmaceutical Co Ltd (000952) holds total assets worth CN¥2.29 Billion CNY (≈ $335.75 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Hubei Guangji Pharmaceutical Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Hubei Guangji Pharmaceutical Co Ltd - Total Assets Trend (1996–2025)
This chart illustrates how Hubei Guangji Pharmaceutical Co Ltd's total assets have evolved over time, based on quarterly financial data. Explore Hubei Guangji Pharmaceutical Co Ltd (000952) long-term investment share to see how much of total assets are deployed in long-term investments.
Hubei Guangji Pharmaceutical Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Hubei Guangji Pharmaceutical Co Ltd's total assets of CN¥2.29 Billion consist of 36.5% current assets and 63.5% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 12.0% |
| Accounts Receivable | CN¥209.40 Million | 9.1% |
| Inventory | CN¥257.65 Million | 11.1% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥203.82 Million | 8.8% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (1996–2025)
This chart illustrates how Hubei Guangji Pharmaceutical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Hubei Guangji Pharmaceutical Co Ltd (000952) total market value.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Hubei Guangji Pharmaceutical Co Ltd's current assets represent 36.5% of total assets in 2025, a decrease from 44.6% in 1996.
- Cash Position: Cash and equivalents constituted 12.0% of total assets in 2025, up from 1.1% in 1996.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, a decrease from 15.0% in 1996.
- Asset Diversification: The largest asset category is inventory at 11.1% of total assets.
Hubei Guangji Pharmaceutical Co Ltd Competitors by Total Assets
Key competitors of Hubei Guangji Pharmaceutical Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
AstraZeneca PLC
F:ZEGA
|
Germany | €114.46 Billion |
|
AstraZeneca PLC
NASDAQ:AZN
|
USA | $114.02 Billion |
|
Novartis AG
SW:NOVN
|
Switzerland | CHF118.89 Billion |
|
Pfizer Inc
SA:PFIZ34
|
Brazil | R$207.62 Billion |
|
Pfizer Inc
NYSE:PFE
|
USA | $207.62 Billion |
|
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.
SHE:301096
|
China | CN¥3.80 Billion |
|
Hunan Jingfeng Pharmaceutical
SHE:000908
|
China | CN¥877.99 Million |
|
Zhejiang Int'L Group Co Ltd
SHE:000411
|
China | CN¥17.31 Billion |
Hubei Guangji Pharmaceutical Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.62 | 0.93 | 1.28 |
| Quick Ratio | 0.46 | 0.62 | 0.93 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥-532.93 Million | CN¥-78.45 Million | CN¥189.32 Million |
Hubei Guangji Pharmaceutical Co Ltd - Advanced Valuation Insights
This section examines the relationship between Hubei Guangji Pharmaceutical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.36 |
| Latest Market Cap to Assets Ratio | 0.13 |
| Asset Growth Rate (YoY) | -17.2% |
| Total Assets | CN¥2.31 Billion |
| Market Capitalization | $302.41 Million USD |
Valuation Analysis
Below Book Valuation: The market values Hubei Guangji Pharmaceutical Co Ltd's assets below their book value (0.13x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Hubei Guangji Pharmaceutical Co Ltd's assets decreased by 17.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Hubei Guangji Pharmaceutical Co Ltd (1996–2025)
The table below shows the annual total assets of Hubei Guangji Pharmaceutical Co Ltd from 1996 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥2.31 Billion ≈ $338.39 Million |
-17.22% |
| 2024-12-31 | CN¥2.79 Billion ≈ $408.79 Million |
-7.79% |
| 2023-12-31 | CN¥3.03 Billion ≈ $443.31 Million |
+22.70% |
| 2022-12-31 | CN¥2.47 Billion ≈ $361.30 Million |
+20.51% |
| 2021-12-31 | CN¥2.05 Billion ≈ $299.82 Million |
+3.51% |
| 2020-12-31 | CN¥1.98 Billion ≈ $289.65 Million |
+12.05% |
| 2019-12-31 | CN¥1.77 Billion ≈ $258.50 Million |
+4.32% |
| 2018-12-31 | CN¥1.69 Billion ≈ $247.78 Million |
+3.13% |
| 2017-12-31 | CN¥1.64 Billion ≈ $240.26 Million |
+0.49% |
| 2016-12-31 | CN¥1.63 Billion ≈ $239.09 Million |
+0.81% |
| 2015-12-31 | CN¥1.62 Billion ≈ $237.16 Million |
+2.42% |
| 2014-12-31 | CN¥1.58 Billion ≈ $231.57 Million |
+1.97% |
| 2013-12-31 | CN¥1.55 Billion ≈ $227.08 Million |
-0.27% |
| 2012-12-31 | CN¥1.56 Billion ≈ $227.69 Million |
+3.27% |
| 2011-12-31 | CN¥1.51 Billion ≈ $220.47 Million |
+8.83% |
| 2010-12-31 | CN¥1.38 Billion ≈ $202.58 Million |
+6.18% |
| 2009-12-31 | CN¥1.30 Billion ≈ $190.79 Million |
+8.02% |
| 2008-12-31 | CN¥1.21 Billion ≈ $176.63 Million |
+20.86% |
| 2007-12-31 | CN¥998.76 Million ≈ $146.15 Million |
+27.23% |
| 2006-12-31 | CN¥785.02 Million ≈ $114.87 Million |
-11.04% |
| 2005-12-31 | CN¥882.44 Million ≈ $129.13 Million |
-3.24% |
| 2004-12-31 | CN¥911.95 Million ≈ $133.45 Million |
+5.19% |
| 2003-12-31 | CN¥866.94 Million ≈ $126.86 Million |
+5.74% |
| 2002-12-31 | CN¥819.91 Million ≈ $119.98 Million |
+7.62% |
| 2001-12-31 | CN¥761.83 Million ≈ $111.48 Million |
+12.66% |
| 2000-12-31 | CN¥676.22 Million ≈ $98.95 Million |
+4.23% |
| 1999-12-31 | CN¥648.78 Million ≈ $94.94 Million |
+71.29% |
| 1998-12-31 | CN¥378.76 Million ≈ $55.42 Million |
+13.72% |
| 1997-12-31 | CN¥333.05 Million ≈ $48.74 Million |
+36.00% |
| 1996-12-31 | CN¥244.89 Million ≈ $35.84 Million |
-- |
About Hubei Guangji Pharmaceutical Co Ltd
Hubei Guangji Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical raw materials, pharmaceutical preparations, and feed additives in China and internationally. It also exports its products. The company was founded in 1969 and is based in Wuxue, China.